Urethroplasty using a tissue-engineered urethral acellular matrix graft is a promising option for reconstruction of severe urethral stenosis.
A urologist on why the time is right to let go
"It is the right time and I have been fortunate to have such great people to work with locally and nationally," a urologist writes.
How APPs can bridge the gap in urologist shortages
In this episode, Janelle Bunce, PA-C, highlights the role that advanced practice providers can play in filling the gaps created by the growing workforce shortages in urology.
Genomic structural variant may drive development of rare kidney cancer
The findings suggest that drug therapies targeting the NOTCH1 gene may serve as an alternative treatment option for patients with kidney cancer in whom surgery is not recommended.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
Revolutionizing Prostate Cancer Imaging with PSMA PET-CT
In the first article of this series, Naveen Kella, MD, discusses the transformative impact of PSMA PET-CT imaging on prostate cancer diagnosis, highlighting its advantages and addressing clinical challenges and guidelines in this evolving field.
CMS grants Transitional Pass-Through payment status to flotufolastat F 18
The reimbursement code for flotufolastat F 18 will be effective October 1, 2023.
2 Clarke Drive Cranbury, NJ 08512